CircCDYL Serves as a New Biomarker in Mantle Cell Lymphoma and Promotes Cell Proliferation

References

• Herrmann A, Hoster E, Zwingers T, et al. Improvement of overall survival in advanced stage mantle cell lymphoma. J Clin Oncol. 2009;27(4 ):511–518. doi:10.1200/JCO.2008.16.843519075279
   PubMed Web of Science ®Google Scholar
• Li W, Xue W, Wang X, et al. MiR-199a mediated the dissemination of human mantle cell lymphoma by interacting with the CCR7/CCL21 pair. Anticancer Drugs. 2018;29(9 ):861–870. doi:10.1097/CAD.000000000000065629979193
   PubMed Web of Science ®Google Scholar
• Vose JM. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management. Am J Hematol. 2017;92(8 ):806–813. doi:10.1002/ajh.2479728699667
   PubMed Web of Science ®Google Scholar
• Maddocks K. Update on mantle cell lymphoma. Blood. 2018;132(16 ):1647–1656. doi:10.1182/blood-2018-03-79139230154113
   PubMed Web of Science ®Google Scholar
• Mei M, Zhang M. Non-coding RNAs in natural killer/T-cell lymphoma. Front Oncol. 2019;9:515. doi:10.3389/fonc.2019.0051531263681
   PubMed Web of Science ®Google Scholar
• Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. 2006;15 Spec No 1:R17–29. doi:10.1093/hmg/ddl04616651366
   PubMed Web of Science ®Google Scholar
• Lasda E, Parker R. Circular RNAs: diversity of form and function. RNA (New York, NY). 2014;20(12 ):1829–1842. doi:10.1261/rna.047126.114
   PubMed Web of Science ®Google Scholar
• Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4 ):381–388. doi:10.1080/15476286.2015.102027125746834
   PubMed Web of Science ®Google Scholar
• Rybak-Wolf A, Stottmeister C, Glazar P, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell. 2015;58(5 ):870–885. doi:10.1016/j.molcel.2015.03.02725921068
   PubMed Web of Science ®Google Scholar
• Du WW, Yang W, Liu E, Yang Z, Dhaliwal P, Yang BB. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res. 2016;44(6 ):2846–2858. doi:10.1093/nar/gkw02726861625
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441 ):333–338. doi:10.1038/nature1192823446348
   PubMed Web of Science ®Google Scholar
• Dahl M, Daugaard I, Andersen MS, et al. Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies. Lab Invest. 2018;98(12 ):1657–1669. doi:10.1038/s41374-018-0108-630087459
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue ):D92–97. doi:10.1093/nar/gkt124824297251
   PubMed Web of Science ®Google Scholar
• Chou CH, Chang NW, Shrestha S, et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res. 2016;44(D1 ):D239–247. doi:10.1093/nar/gkv125826590260
   PubMed Web of Science ®Google Scholar
• Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1 ):44–57. doi:10.1038/nprot.2008.21119131956
   PubMed Web of Science ®Google Scholar
• Vogt N, Dai B, Erdmann T, Berdel WE, Lenz G. The molecular pathogenesis of mantle cell lymphoma. Leuk Lymphoma. 2017;58(7 ):1530–1537. doi:10.1080/10428194.2016.124896527894215
   PubMed Web of Science ®Google Scholar
• Xu W, Li JY. SOX11 expression in mantle cell lymphoma. Leuk Lymphoma. 2010;51(11 ):1962–1967. doi:10.3109/10428194.2010.51496820919851
   PubMed Web of Science ®Google Scholar
• Fan Z, Wang X, Li P, Mei C, Zhang M, Zhao C. Overexpression of lncRNA GATA6-AS inhibits cancer cell proliferation in mantle cell lymphoma by downregulating GLUT1. Oncol Lett. 2019;18(3 ):2443–2447. doi:10.3892/ol.2019.1054031402946
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Veno MT, Kjems J. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5 ):555–565. doi:10.1038/onc.2017.36128991235
   PubMed Web of Science ®Google Scholar
• Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1 ):94. doi:10.1186/s12943-017-0663-228535767
   PubMed Web of Science ®Google Scholar
• Xu H, Gong Z, Shen Y, Fang Y, Zhong S. Circular RNA expression in extracellular vesicles isolated from serum of patients with endometrial cancer. Epigenomics. 2018;10(2 ):187–197. doi:10.2217/epi-2017-010929334253
   PubMed Web of Science ®Google Scholar
• Li J, Li Z, Jiang P, et al. Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis. J Exp Clin Cancer Res. 2018;37(1 ):177. doi:10.1186/s13046-018-0822-330064461
   PubMed Web of Science ®Google Scholar
• Liu Y, Lai S, Ma W, et al. CDYL suppresses epileptogenesis in mice through repression of axonal Nav1.6 sodium channel expression. Nat Commun. 2017;8(1 ):355. doi:10.1038/s41467-017-00368-z28842554
   PubMedGoogle Scholar
• Sun J, Zhang H, Tao D, et al. CircCDYL inhibits the expression of C-MYC to suppress cell growth and migration in bladder cancer. Artif Cells Nanomed Biotechnol. 2019;47(1 ):1349–1356. doi:10.1080/21691401.2019.159694130968727
   PubMed Web of Science ®Google Scholar
• Wei Y, Chen X, Liang C, et al. A noncoding regulatory RNAs network driven by circ-CDYL acts specifically in the early stages hepatocellular carcinoma. Hepatology (Baltimore, Md). 2019. doi:10.1002/hep.30795
   Web of Science ®Google Scholar
• Lin J, Cai D, Li W, et al. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer. Clin Biochem. 2019. doi:10.1016/j.clinbiochem.2019.10.012
   Web of Science ®Google Scholar
• Yu J, Ding WB, Wang MC, et al. Plasma circular RNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma: a large-scale, multicenter study. Int J Cancer. 2019. doi:10.1002/ijc.32647
   Web of Science ®Google Scholar
• Wang X, Sehgal L, Jain N, Khashab T, Mathur R, Samaniego F. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2. J Transl Med. 2016;14(1 ):346. doi:10.1186/s12967-016-1100-927998273
   PubMedGoogle Scholar
• Letestu R, Ugo V, Valensi F, et al. Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disorders. Leukemia. 2004;18(5 ):953–961. doi:10.1038/sj.leu.240333715029207
   PubMed Web of Science ®Google Scholar
• Pinyol M, Hernandez L, Cazorla M, et al. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood. 1997;89(1 ):272–280. doi:10.1182/blood.V89.1.2728978301
   PubMed Web of Science ®Google Scholar
• Lund K, Adams PD, Copland M. EZH2 in normal and malignant hematopoiesis. Leukemia. 2014;28(1 ):44–49. doi:10.1038/leu.2013.28824097338
   PubMed Web of Science ®Google Scholar
• Li W, Bi C, Han Y, et al. Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma. Cancer Biol Med. 2019;16(3 ):530–541. doi:10.20892/j.issn.2095-3941.2018.038031565482
   PubMed Web of Science ®Google Scholar
• Lin YL, Zou ZK, Su HY, Huang YQ. [Expression of MiR101 and EZH2 in patients with mantle cell lymphoma and its clinical significance]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019;27(3 ):820–826. doi:10.19746/j.cnki.issn.1009-2137.2019.03.02931204938
   PubMedGoogle Scholar
• Kridel R, Meissner B, Rogic S, et al. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood. 2012;119(9 ):1963–1971. doi:10.1182/blood-2011-11-39147422210878
   PubMed Web of Science ®Google Scholar
• Huang YQ, Huang XL, Ma XD. [Effect of silencing NOTCH1 gene by shRNA interference on AKT/mTOR pathway in mantle cell lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014;22(6 ):1616–1620. doi:10.7534/j.issn.1009-2137.2014.06.02125543484
   PubMedGoogle Scholar